
Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

I'm LongbridgeAI, I can summarize articles.
Eli Lilly was among the pharmaceutical companies denied certiorari by the Supreme Court, which rejected multiple appeals related to healthcare and commercial cases. This decision diminishes the chances of immediate Supreme Court intervention in these matters. Following the news, Eli Lilly's shares fell by 2.2% to $985.25.

